UC engineers develop saliva test to detect depression and anxiety

University of Cincinnati engineers created a new device to help doctors diagnose depression and anxiety.

UC College of Engineering and Applied Science Distinguished Research Professor Chong Ahn and his students developed a "lab-on-a-chip" device that measures the stress hormone cortisol from a patient's saliva. Knowing if a patient has elevated stress hormones can provide useful diagnostic information even if patients do not report feelings of anxiety, stress or depression in a standard mental health questionnaire.

Mental health disorders affect more than 400 million people around the world. Stress disorders such as anxiety and depression are among the leading causes of disability worldwide. Prolonged cortisol elevation is linked to numerous mental health disorders, including depression and anxiety.

UC researchers created a lab-on-a-chip system to track a patient's cortisol levels. It consists of a disposable collection device that a person puts in their mouth which is then inserted into a reader. The reader can transmit results in minutes to a portable analyzer and smartphone.

The study was published in the journal Biomedical Microdevices.

Mental health care can be an urgent situation. And so these tests will help doctors make timely interventions."

Distinguished Research Professor Chong Ahn, UC College of Engineering and Applied Science

Patients can do the testing themselves and share results with doctors with a web app, he said.

Study co-author UC doctoral student Supreeth Setty is working on a related project for his dissertation that examines another hormone (dehydroepiandrosterone) that goes by the acronym DHEA. That hormone helps to counteract the effects of too much cortisol in the body. Research has shown that high ratios of cortisol to DHEA are indicators of chronic stress associated with conditions such as depression and anxiety.

Setty said the tests provide clinicians with objective evidence to supplement traditional screenings such as the patient health questionnaire.

"Point-of-care testing is a practical way to make results available quickly for everyone," he said.

Unlike mental health questionnaires that can be more subjective because they rely on a patient's candor and self-awareness, the cortisol and DHEA tests are objective and can raise a red flag about a patient's levels of stress, Setty said.

"The next step would be to collaborate with psychiatrists and conduct clinical trials to see if our platform works as expected," Setty said.

UC doctoral graduate Vinitha Thiyagarajan Upaassana was the lead author of the study with Setty and co-author and UC doctoral student Heeyong Jang. The project was partially funded by UC's Technology Accelerator Project.

UC researchers say their technique can be used to diagnose other health issues.

In particular, they examined troponin, a protein that gets released into the bloodstream when patients suffer damage to their hearts from conditions such as a heart attack. The amount of the protein released depends on how much damage the heart sustains. High cardiac troponin levels in combination with symptoms such as chest pain can indicate a heart attack in progress.

In a paper published in the journal Analytical Chemistry, Jang, Setty and Ahn unveiled an innovative new device for a rapid and effective point-of-care biochemical test that measures troponin from a drop of blood.

"Once you survive a heart attack there is an increased probability of having another heart attack," Jang said. "We can monitor troponin in the blood on a daily basis and hopefully get valuable information. The test provides immediate results, which is important when a patient is in need of immediate care."

UC researchers also developed a new point-of-care-testing platform for COVID-19. Researchers unveiled their new design in the journal Sensors and Diagnostics.